VE 5773
Alternative Names: VE-5773Latest Information Update: 25 Jan 2023
At a glance
- Originator Verseon
- Class Hepatoprotectants; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Non-alcoholic steatohepatitis
Most Recent Events
- 11 Jan 2023 Early research in Non-alcoholic steatohepatitis in USA (unspecified route) before January 2023 (Verseon pipeline, January 2023)